Why is Bal Pharma falling/rising?

As of 29-Aug, Bal Pharma Ltd's stock price is currently at Rs 88.00, reflecting an increase of Rs 2.1 or 2.44%. Today, the stock opened with a gain of 2.15% and reached an intraday high of Rs 88.08, outperforming its sector by 2.41%. However, despite this positive movement today, the stock has shown a significant decline over the past year, with a return of -42.33%. Additionally, the stock is trading below its moving averages across various time frames, indicating a bearish trend. The company has also reported negative results for the last three consecutive quarters, with net sales falling by -11.42% and a decrease in profit after tax by -19.2%. While the stock is trading at a discount compared to its peers, the weak long-term fundamentals and declining investor participation suggest underlying issues affecting its performance.
In the broader market context, Bal Pharma's short-term performance of -0.56% over the past week contrasts with the Sensex, which has declined by -1.84%. This indicates that the stock has outperformed the benchmark in the short term, despite its overall poor performance in the last year and beyond. The company's weak long-term growth, as evidenced by a low return on capital employed and a high debt-to-EBITDA ratio, further complicates its outlook. Overall, while the stock has seen a slight rise today, the persistent negative trends in its financial performance and market participation raise concerns about its sustainability in the near future.